HR 2829 RFS 
(b) REPEAL
OF SUPERSEDED PROVISIONS.—The 
Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is repealed. 
SEC. 13. DRUG INTERDICTION. 
(a) IN GENERAL.—Subsections (a) and (b) of section 
711 (21 U.S.C. 1710) are amended to read as follows: 
‘‘(a) UNITED
STATES
INTERDICTION
COORDI-
NATOR.— 
‘‘(1) IN GENERAL.—The Deputy Director for 
Supply Reduction in the Office shall serve as the 
United States Interdiction Coordinator, and shall 
perform the duties of that position described in 
paragraph (2) and such other duties as may be de-
termined by the Director with respect to coordina-
tion of efforts to interdict illicit drugs from entering 
the United States. 
‘‘(2) RESPONSIBILITIES.—The United States 
Interdiction Coordinator shall be responsible to the 
Director for— 
‘‘(A) coordinating the interdiction activities 
of the National Drug Control Program agencies 
to ensure consistency with the National Drug 
Control Strategy; 
‘‘(B) on behalf of the Director, developing 
and issuing, on or before March 1 of each year 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00094
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
and in accordance with paragraph (3), a Na-
tional Interdiction Command and Control Plan 
to ensure the coordination and consistency de-
scribed in subparagraph (A); 
‘‘(C) assessing the sufficiency of assets 
committed to illicit drug interdiction by the rel-
evant National Drug Control Program agencies; 
and 
‘‘(D) advising the Director on the efforts 
of each National Drug Control Program agency 
to implement the National Interdiction Com-
mand and Control Plan. 
‘‘(3) STAFF.—The Director shall assign such 
permanent staff of the Office as he considers appro-
priate to assist the United States Interdiction Coor-
dinator to carry out the responsibilities described in 
paragraph (2), and may also, at his discretion, re-
quest that appropriate National Drug Control Pro-
gram agencies detail or assign staff to the Office of 
Supply Reduction for that purpose. 
‘‘(4) NATIONAL INTERDICTION COMMAND AND 
CONTROL PLAN.— 
‘‘(A) PURPOSES.—The National Interdic-
tion Command and Control Plan shall— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00095
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(i) set forth the Government’s strat-
egy for drug interdiction; 
‘‘(ii) state the specific roles and re-
sponsibilities of the relevant National Drug 
Control Program agencies for imple-
menting that strategy; and 
‘‘(iii) identify the specific resources re-
quired to enable the relevant National 
Drug Control Program agencies to imple-
ment that strategy. 
‘‘(B) CONSULTATION WITH OTHER AGEN-
CIES.—The United States Interdiction Coordi-
nator shall issue the National Interdiction Com-
mand and Control Plan in consultation with the 
other members of the Interdiction Committee 
described in subsection (b). 
‘‘(C) LIMITATION.—The National Interdic-
tion Command and Control Plan shall not 
change existing agency authorities or the laws 
governing interagency relationships, but may in-
clude recommendations about changes to such 
authorities or laws. 
‘‘(D) REPORT TO CONGRESS.—On or be-
fore March 1 of each year, the United States 
Interdiction Coordinator shall provide a report 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00096
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
on behalf of the Director to the appropriate 
congressional committees, to the Committee on 
Armed Services and the Committee on Home-
land Security of the House of Representatives, 
and to the Committee on Homeland Security 
and Governmental Affairs and the Committee 
on Armed Services of the Senate, which shall 
include— 
‘‘(i) a copy of that year’s National 
Interdiction Command and Control Plan; 
‘‘(ii) information for the previous 10 
years regarding the number and type of 
seizures of drugs by each National Drug 
Control Program agency conducting drug 
interdiction activities, as well as statistical 
information on the geographic areas of 
such seizures; and 
‘‘(iii) information for the previous 10 
years regarding the number of air and 
maritime patrol hours undertaken by each 
National Drug Control Program agency 
conducting drug interdiction activities, as 
well as statistical information on the geo-
graphic areas in which such patrol hours 
took place. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00097
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(E) TREATMENT OF CLASSIFIED OR LAW 
ENFORCEMENT SENSITIVE INFORMATION.—Any 
content of the report described in subparagraph 
(D) that involves information classified under 
criteria established by an Executive order, or 
the public disclosure of which, as determined by 
the Director, the Director of National Intel-
ligence, or the head of any Federal Government 
agency the activities of which are described in 
the plan, would be detrimental to the law en-
forcement or national security activities of any 
Federal, State, or local agency, shall be pre-
sented to Congress separately from the rest of 
the report. 
‘‘(b) INTERDICTION COMMITTEE.— 
‘‘(1) IN
GENERAL.—The Interdiction Com-
mittee shall meet to— 
‘‘(A) discuss and resolve issues related to 
the coordination, oversight and integration of 
international, border, and domestic drug inter-
diction efforts in support of the National Drug 
Control Strategy; 
‘‘(B) review the annual National Interdic-
tion Command and Control Plan, and provide 
advice to the Director and the United States 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00098
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
Interdiction Coordinator concerning that plan; 
and 
‘‘(C) provide such other advice to the Di-
rector concerning drug interdiction strategy and 
policies as the committee determines is appro-
priate. 
‘‘(2) MEMBERSHIP.—The membership of the 
Interdiction Committee shall consist of— 
‘‘(A) the Commissioner of the bureau of 
Customs and Border Protection at the Depart-
ment of Homeland Security; 
‘‘(B) the Assistant Secretary of the bureau 
of Immigration and Customs Enforcement at 
the Department of Homeland Security; 
‘‘(C) the Commandant of the United 
States Coast Guard; 
‘‘(D) the Director of the Office of Counter-
narcotics Enforcement at the Department of 
Homeland Security; 
‘‘(E) the Administrator of the Drug En-
forcement Administration; 
‘‘(F) the Assistant Secretary of State for 
International Narcotics and Law Enforcement 
Affairs; 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00099
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
100 
HR 2829 RFS 
‘‘(G) the Assistant Secretary of Defense 
for Special Operations and Low Intensity Con-
flict; 
‘‘(H) the Deputy Director for Supply Re-
duction of the Office of National Drug Control 
Policy, acting in his role as the United States 
Interdiction Coordinator; 
‘‘(I) the director of the Crime and Nar-
cotics Center of the Central Intelligence Agen-
cy; 
‘‘(J) the Deputy Director for State and 
Local Affairs of the Office of National Drug 
Control Policy; 
‘‘(K) the Chief of the National Guard Bu-
reau’s Counterdrug Program; and 
‘‘(L) such additional persons as may be de-
termined by the Director. 
‘‘(3) CHAIRMAN.—The Director shall designate 
one of the members of the Interdiction Committee to 
serve as chairman. 
‘‘(4) MEETINGS.—The members of the Interdic-
tion Committee shall meet, in person and not 
through any delegate or representative, at least once 
per calendar year, prior to March 1. At the call of 
either the Director or the current chairman, the 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00100
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
101 
HR 2829 RFS 
Interdiction Committee may hold additional meet-
ings, which shall be attended by the members either 
in person, or through such delegates or representa-
tives as they may choose. 
‘‘(5) REPORT.—Not later than September 30 of 
each year, the chairman of the Interdiction Com-
mittee shall submit a report to the Director and to 
the appropriate congressional committees describing 
the results of the meetings and any significant find-
ings of the Committee during the previous 12 
months. Any content of such a report that involves 
information classified under criteria established by 
an Executive order, or whose public disclosure, as 
determined by the Director, the chairman, or any 
member, would be detrimental to the law enforce-
ment or national security activities of any Federal, 
State, or local agency, shall be presented to Con-
gress separately from the rest of the report.’’. 
(b) CONFORMING AMENDMENT TO HOMELAND SE-
CURITY ACT OF 2002.—Section 878 of the Homeland Se-
curity Act of 2002 (6 U.S.C. 458) is amended— 
(1) in subsection (c), by striking ‘‘Except as 
provided in subsection (d), the’’ and inserting 
‘‘The’’; and 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00101
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
102 
HR 2829 RFS 
(2) by striking subsection (d) and redesignating 
subsections (e), (f), and (g) as subsections (d), (e), 
and (f), respectively. 
SEC. 14. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO SHUT DOWN IL-
LICIT DRUG MARKET HOT-SPOTS BY DETER-
RING DRUG DEALERS OR ALTERING THE DY-
NAMIC OF DRUG SALES. 
Sections 713 and 714 (21 U.S.C. 1711) are redesig-
nated as sections 715 and 716, respectively, and after sec-
tion 712 (21 U.S.C. 1710) insert the following new sec-
tion: 
‘‘SEC. 713 AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO SHUT DOWN IL-
LICIT DRUG MARKET HOT-SPOTS BY DETER-
RING DRUG DEALERS OR ALTERING THE DY-
NAMIC OF DRUG SALES. 
‘‘(a) AWARDS REQUIRED.—The Director shall make 
competitive awards for demonstration programs by eligible 
partnerships for the purpose of shutting down local illicit 
drug market hot-spots and reducing drug-related crime 
through evidence-based, strategic problem-solving inter-
ventions that deter drug dealers or alter the dynamic of 
drug sales. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00102
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
103 
HR 2829 RFS 
‘‘(b) USE OF AWARD AMOUNTS.—Award amounts re-
ceived under this section shall be used— 
‘‘(1) to support the efforts of the agencies, or-
ganizations, and researchers included in the eligible 
partnership; 
‘‘(2) to develop and field a directed and credible 
deterrent threat; and 
‘‘(3) to strengthen rehabilitation efforts through 
such means as job training, drug treatment, or other 
services. 
‘‘(c) ELIGIBLE PARTNERSHIP DEFINED.—In this 
section, the term ‘eligible partnership’ means a working 
group whose application to the Director— 
‘‘(1) identifies the roles played, and certifies the 
involvement of, three or more agencies or organiza-
tions, which may include— 
‘‘(A) State or local agencies (such as those 
carrying out police, probation, prosecution, 
courts, corrections, parole, or treatment func-
tions); 
‘‘(B) Federal agencies (such as the Drug 
Enforcement Agency, the Bureau of Alcohol, 
Tobacco, Firearms, and Explosives, and United 
States Attorney offices); and 
‘‘(C) community-based organizations; 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00103
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
104 
HR 2829 RFS 
‘‘(2) includes a qualified researcher; 
‘‘(3) includes a plan for identifying the impact 
players in, and assessing the nature and dynamic of, 
the local drug market and its related crime through 
information gathering and analysis; 
‘‘(4) includes a plan for developing an evidence- 
based strategic intervention aimed at quickly and 
sustainably eradicating the local drug market by de-
terring drug dealers or altering the dynamic of drug 
sales; and 
‘‘(5) includes a plan that describes the method-
ology and outcome measures proposed for evaluating 
the impact of that strategic intervention on drug 
sales, neighborhood disorder, and crime. 
‘‘(d) REPORTS TO CONGRESS.— 
‘‘(1) INTERIM REPORT.—Not later than June 1, 
2009, the Director shall submit to Congress a report 
that identifies the best practices in drug market 
eradication, including the best practices identified 
through the activities funded under this section. 
‘‘(2) FINAL REPORT.—Not later than June 1, 
2010, the Director shall submit to Congress a report 
on the demonstration programs funded under this 
section, including on the matters specified in para-
graph (1). 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00104
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
105 
HR 2829 RFS 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section 
$10,000,000 for each of fiscal years 2007 through 2009.’’. 
SEC. 15. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO COERCE ABSTI-
NENCE 
IN 
CHRONIC 
HARD-DRUG 
USERS 
UNDER COMMUNITY SUPERVISION THROUGH 
THE USE OF DRUG TESTING AND SANCTIONS. 
After section 713, as inserted by section 14 of this 
Act, insert the following new section: 
‘‘SEC. 714. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO COERCE ABSTI-
NENCE 
IN 
CHRONIC 
HARD-DRUG 
USERS 
UNDER COMMUNITY SUPERVISION THROUGH 
THE USE OF DRUG TESTING AND SANCTIONS. 
‘‘(a) AWARDS REQUIRED.—The Director shall make 
competitive awards to fund demonstration programs by el-
igible partnerships for the purpose of reducing the use of 
illicit drugs by chronic hard-drug users living in the com-
munity while under the supervision of the criminal justice 
system. 
‘‘(b) USE OF AWARD AMOUNTS.—Award amounts re-
ceived under this section shall be used— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00105
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
106 
HR 2829 RFS 
‘‘(1) to support the efforts of the agencies, or-
ganizations, and researchers included in the eligible 
partnership; 
‘‘(2) to develop and field a drug testing and 
graduated sanctions program for chronic hard-drug 
users living in the community under criminal justice 
supervision; and 
‘‘(3) to assist individuals described in sub-
section (a) by strengthening rehabilitation efforts 
through such means as job training, drug treatment, 
or other services. 
‘‘(c) ELIGIBLE PARTNERSHIP DEFINED.—In this 
section, the term ‘eligible partnership’ means a working 
group whose application to the Director— 
‘‘(1) identifies the roles played, and certifies the 
involvement of, two or more agencies or organiza-
tions, which may include— 
‘‘(A) State or local agencies (such as those 
carrying out police, probation, prosecution, 
courts, corrections, parole, or treatment func-
tions); 
‘‘(B) Federal agencies (such as the Drug 
Enforcement Agency, the Bureau of Alcohol, 
Tobacco, Firearms, and Explosives, and United 
States Attorney offices); and 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00106
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
107 
HR 2829 RFS 
‘‘(C) community-based organizations; 
‘‘(2) includes a qualified researcher; 
‘‘(3) includes a plan for using judicial or other 
criminal justice authority to administer drug tests to 
individuals described in subsection (a) at least twice 
a week, and to swiftly and certainly impose a known 
set of graduated sanctions for non-compliance with 
community-release provisions relating to drug absti-
nence (whether imposed as a pre-trial, probation, or 
parole condition or otherwise); 
‘‘(4) includes a strategy for responding to a 
range of substance use and abuse problems and a 
range of criminal histories; 
‘‘(5) includes a plan for integrating data infra-
structure among the agencies and organizations in-
cluded in the eligible partnership to enable seamless, 
real-time tracking of individuals described in sub-
section (a); 
‘‘(6) includes a plan to monitor and measure 
the progress toward reducing the percentage of the 
population of individuals described in subsection (a) 
who, upon being summoned for a drug test, either 
fail to show up or who test positive for drugs. 
‘‘(d) REPORTS TO CONGRESS.— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00107
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
108 
HR 2829 RFS 
‘‘(1) INTERIM REPORT.—Not later than June 1, 
2009, the Director shall submit to Congress a report 
that identifies the best practices in reducing the use 
of illicit drugs by chronic hard-drug users, including 
the best practices identified through the activities 
funded under this section. 
‘‘(2) FINAL REPORT.—Not later than June 1, 
2010, the Director shall submit to Congress a report 
on the demonstration programs funded under this 
section, including on the matters specified in para-
graph (1). 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section 
$10,000,000 for each of fiscal years 2007 through 2009.’’. 
SEC. 16. AUTHORIZATION OF APPROPRIATIONS. 
Section 716 (21 U.S.C. 1711), as redesignated by 
section 14 of this Act, is amended— 
(1) by striking ‘‘title,’’ and inserting ‘‘title, ex-
cept activities for which amounts are otherwise spe-
cifically authorized by this title,’’; and 
(2) by striking ‘‘1999 through 2003’’ and in-
serting ‘‘2007 through 2011’’. 
SEC. 17. TECHNICAL AMENDMENTS AND REPEAL. 
(a) AMENDMENT TO PUBLIC HEALTH SERVICE ACT 
TO REPLACE OBSOLETE REFERENCES.—Section 464P(c) 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00108
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
109 
HR 2829 RFS 
of the Public Health Service Act (42 U.S.C. 285o–4(c)) 
is amended— 
(1) in paragraph (1), by striking ‘‘under section 
1002 of the Anti-Drug Abuse Act of 1988 (21 
U.S.C. 1501)’’ and inserting ‘‘under section 703 of 
the Office of National Drug Control Policy Reau-
thorization Act of 1998 (21 U.S.C. 1702)’’; and 
(2) in paragraph (2), by striking ‘‘under section 
1005 of the Anti-Drug Abuse Act of 1988 (21 
U.S.C. 1504)’’ and inserting ‘‘under section 706 of 
the Office of National Drug Control Policy Reau-
thorization Act of 1998 (21 U.S.C. 1705)’’. 
(b) REPEAL OF SPECIAL FORFEITURE FUND.—Sec-
tion 6073 of the Asset Forfeiture Amendments Act of 
1988 (21 U.S.C. 1509) is repealed. 
SEC. 18. REQUIREMENT FOR DISCLOSURE OF FEDERAL 
SPONSORSHIP 
OF 
ALL 
FEDERAL 
ADVER-
TISING OR OTHER COMMUNICATION MATE-
RIALS. 
Section 712 is amended to read as follows: 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00109
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
110 
HR 2829 RFS 
‘‘SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL 
SPONSORSHIP 
OF 
ALL 
FEDERAL 
ADVER-
TISING OR OTHER COMMUNICATION MATE-
RIALS. 
‘‘(a) REQUIREMENT.—Each advertisement or other 
communication paid for by the Office, either directly or 
through a contract awarded by the Office, shall include 
a prominent notice informing the target audience that the 
advertisement or other communication is paid for by the 
Office. 
‘‘(b) ADVERTISEMENT
OR
OTHER
COMMUNICA-
TION.—In this section, the term ‘advertisement or other 
communication’ includes— 
‘‘(1) an advertisement disseminated in any 
form, including print or by any electronic means; 
and 
‘‘(2) a communication by an individual in any 
form, including speech, print, or by any electronic 
means.’’. 
SEC. 19. POLICY RELATING TO SYRINGE EXCHANGE PRO-
GRAMS. 
Section 703(a) (21 U.S.C. 1702(a)) is amended by 
adding at the end the following: 
‘‘When developing the national drug control policy, any 
policy of the Director relating to syringe exchange pro-
grams for intravenous drug users shall be based on the 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00110
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
111 
HR 2829 RFS 
best available medical and scientific evidence regarding 
their effectiveness in promoting individual health and pre-
venting the spread of infectious disease, and their impact 
on drug addiction and use. In making any policy relating 
to syringe exchange programs, the Director shall consult 
with the National Institutes of Health and the National 
Academy of Sciences.’’. 
SEC. 20. INTERNATIONAL SUMMIT ON METHAMPHETAMINE 
THREAT. 
(a) SUMMIT REQUIREMENT.—The Director of the 
Office of National Drug Control Policy in the Executive 
Office of the President shall, in consultation with the Sec-
retary of State, the Attorney General, the Secretary of 
Homeland Security, the Secretary of Health and Human 
Services, and the United States Trade Representative, 
seek to convene an international summit on the threat of 
methamphetamine and synthetic drug precursor chemi-
cals. 
(b) PARTICIPATION
OF OTHER COUNTRIES.—The 
Director shall seek to convene the summit with the partici-
pation and involvement of government leaders at the high-
est level from all countries that are direct sources of pre-
cursor chemicals and from all countries that are affected 
by methamphetamine production, trafficking, and use, to 
intensify and coordinate an effective international re-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00111
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS